BCL9L and breast cancer: Our next strategy is to examine in more detail the role of BCL9L/Wnt/β-catenin signalling in the invasiveness and progression of BC also EMT transition markers using 3D models such as spheroid and the ex vivo porcine bladder organ model as described elsewhere [77].